“circHIF1A/miR-361-5p/HIF1A” formed a ceRNA feedback network, which affected the glycometabolism of CRC cells, and miR-361-5p and HIF1A intervention could reverse circHIF1A-mediated resistance to Cetuximab. This evidence concerns the gene HIF1A and colorectal carcinoma.